Arzoo Puri, MSc Biomedical Science
R&D Head, Director, Department of Research and Development
Cannazo India (company), India, India
Ms. Arzoo Puri is the Director and Research & Development (R&D) Head at Cannazo India, a Hemp leaf extract, nanotechnology-based phytomedicine company. Her R&D team at State of the Art Research Lab is currently carrying out multiple research projects with respect to, novel API (Active Pharmaceutical Ingredient) formulation of unknown phytochemicals to treat patients suffering from chronic diseases, endocannabinoid system and its receptors namely CB1 & CB2, drug delivery and pharmacokinetic studies of existing compounds. She is also currently working with AZoNetwork UK Ltd as a scientific writer and is now an editorial board member at IJFSC. She has a Master?s degree in biomedical sciences (NMIMS), and in the past has been affiliated with Nanobios Lab, IIT-Bombay, Armed Forces Medical Stores Depot (AFMSD), Ministry of Defence, Government of India and Eureka (NMIMS? monthly science newsletter). Her work (including articles and book chapters) has been published in reputed scientific journals such as Journal of Forensic Science & Criminology. Her core interests lie in nanotechnology-based research, cannabis science and biomedical science. Her research goals are mainly directed toward the field of herbal/ nano-formulations, point-of-care testing devices, drug delivery, medical diseases, and nano-materials such as graphene quantum dots.
Nanotechnology, Cannabis Science, Biomedical Science